IONIS PHARMACEUTICALS INC ($IONS)
Filing Information
| Accession Number | 0000874015-26-000026 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
89,889
Total Value
$3,284,986.58
P&L
+inf% (+$1,384,305.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP Research | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 5,125 | $60.89 | $312,061.25 | 35,578 | Direct | โ | View Details | |
EVP Research | Common Stock | โ | Jan 2, 2026 | Sale | 5,125 | $78.57 | $402,671.25 | 30,453 | Direct | โ | View Details | |
EVP Research | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 18,338 | $60.89 | $1,116,600.82 | 48,791 | Direct | โ | View Details | |
EVP Research | Common Stock | โ | Jan 2, 2026 | Sale | 18,338 | $79.27 | $1,453,653.26 | 30,453 | Direct | โ | View Details | |
EVP Research | Non-Qualified Stock Option (right to buy) | Derivative | Jan 2, 2026 | Exercise/Conversion | 5,125 | $0.00 | $0.00 | 22,403 | Direct | โ | View Details | |
EVP Research | Non-Qualified Stock Option (right to buy) | Derivative | Jan 2, 2026 | Exercise/Conversion | 18,338 | $0.00 | $0.00 | 4,065 | Direct | โ | View Details | |
EVP Research | Non-Qualified Stock Option (right to buy) | Derivative | Jan 2, 2026 | Grant/Award | 19,350 | $0.00 | $0.00 | 19,350 | Direct | โ | View Details | |
EVP Research | Non-Qualified Stock Option (right to buy) | Derivative | Jan 2, 2026 | Grant/Award | 150 | $0.00 | $0.00 | 150 | Indirect | by Son | View Details |